Clinical Trial Update: An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial update for LYC-30937-EC in moderate chronic plaque-type psoriasis completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• LYC-30937-EC

Snippet

Sponsor: Lycera Corp. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2019-04-02